Diabetic foot ulcer (DFU) is the most typical and expensive sequela of diabetes mellitus, usually resulting in lower-extremity amputation with poor 5-year survival charges. Staphylococcus aureus is probably the most prevalent pathogen remoted from DFU, suggesting adaptation of S. aureus to the distinctive metabolic situations of diabetes.
Diabetes is a fancy metabolic dysfunction with will increase not solely in serum glucose ranges but in addition in ranges of different sugars, together with fructose, mannose, and glucose-6-phosphate (G6P). Nevertheless, the impact of metabolism of those sugars on the pathogenesis of S. aureus just isn’t totally understood.
On this research, we demonstrated that metabolism of G6P, fructose, and mannose induced larger expression of staphylococcal virulence components than did glucose metabolism, however solely G6P results had been impartial of glucose-mediated carbon catabolite repression, suggesting a physiologically related position in diabetes.
Our in vivo research additional demonstrated that G6P was extremely current in pores and skin adipose tissues of diabetic TALLYHO/JngJ mice, and subcutaneous an infection with S. aureus brought about considerably larger tissue necrosis and bacterial burden, in comparison with nondiabetic SWR/J mice.
Lastly, enhanced pathogenesis of S. aureus in diabetic TALLYHO/JngJ mice was considerably attenuated by deletion of the hexose phosphate transport (HPT) system. These outcomes recommend that G6P is a vital metabolic sign for S. aureus, enhancing the virulence in diabetes. A greater understanding of how G6P metabolism is linked to the virulence of S. aureus will result in the event of novel different therapeutics.
Sugars are important vitamins for S. aureus to outlive and proliferate inside the host. As a result of elevated serum glucose ranges are an indicator of diabetes, most research have targeted on the impact of glucose metabolism, and little or no is thought relating to the consequences of metabolism of different sugars on the pathogenesis of S. aureus in diabetes.
On this research, we demonstrated that G6P, which is very current in diabetes, can induce expression of staphylococcal virulence components that trigger extreme tissue necrosis and bacterial burden in pores and skin infections.
Our outcomes spotlight the significance of dietary management of blood sugar ranges, not solely glucose but in addition different extremely metabolizable sugars similar to G6P. A greater understanding of how activation of the HPT system is linked to the virulence of S. aureus will information growth of novel different therapeutics.
Elements Influencing Change in Serum Uric Acid after Administration of the Sodium-Glucose Cotransporter 2 Inhibitor Luseogliflozin in Sufferers With Kind 2 Diabetes Mellitus
Though sodium-glucose cotransporter 2 (SGLT2) inhibitors decrease serum uric acid, their long-term impact on uric acid metabolism just isn’t properly understood. We analyzed pooled information from research whereby sufferers with sort 2 diabetes mellitus (T2DM) acquired luseogliflozin-an SGLT2 inhibitor.
Upon stratifying sufferers by baseline glycated hemoglobin (HbA1c) or serum uric acid, decrease HbA1c or larger serum uric acid stage was related to a larger discount in serum uric acid after remedy.
At week 12 of remedy, a major enhance in urinary glucose/creatinine (Cr) ratio and urinary uric acid clearance/Cr clearance ratio (CUA /CCr ratio) and a major discount in serum uric acid had been noticed.
Comparability of the subgroups of sufferers with a discount or a rise in serum uric acid confirmed that the rise subgroup had a better estimated glomerular filtration price (eGFR) at baseline, and the eGFR was considerably lowered, related to a major discount within the CUA /CCr ratio.
A number of regression evaluation confirmed that the discount in serum uric acid within the luseogliflozin group was strongly related to baseline excessive serum uric acid, low HbA1c ranges, and a rise in eGFR. Luseogliflozin was proven to scale back serum uric acid by enhancing urinary uric acid excretion in affiliation with elevated urinary glucose.
Therapy with luseogliflozin resulted in elevated serum uric acid in some sufferers, which can be as a result of lowered glomerular filtration of uric acid by way of the tubuloglomerular suggestions. SGLT2 inhibitors lowered serum uric acid desirably in sufferers with T2DM with low HbA1c and excessive serum uric acid. This text is protected by copyright. All rights reserved.
Steroid profiling and genetic variants in Chinese language ladies with gestational diabetes mellitus
Earlier research have demonstrated that steroids had been related to gestational diabetes mellitus (GDM). Nevertheless, outcomes from completely different research remained inconsistent, and solely a restricted vary of steroids had been investigated in these research.
Subsequently, we aimed to investigate complete steroid profiling in Chinese language ladies with GDM throughout third-trimester being pregnant. In 97 Chinese language pregnant ladies, we measured steroid profile utilizing a LC-MS/MS technique, and calculated product-to-precursor ratios in metabolic pathways of steroids.
Then sixteen genetic variants of genes encoding steroidogenic enzymes had been genotyped by MassARRAY system. There have been vital variations (P < 0.05) and apparent modifications (fold change <0.67 or >1.5) in steroids (testosterone, estriol, pregnenolone and dehydroepiandrosterone) and product-to-precursor ratios (E2/T and T/AD) between GDM and management teams.
Hepatic insulin resistance (HIR) is taken into account to be an impartial predictor of metabolic problems and performs an necessary position in systemic irritation, which contributes to abnormalities in heart problems (CVD) threat components.
The purpose of this research was to research the connection between HIR and new markers of cardiovascular dangers, together with leptin/adiponectin ratio (L/A), lipoprotein(a) [Lp(a)], and tumor necrosis issue alpha (TNF-α), at comparable entire physique insulin sensitivity in non-diabetic people with or with out CVD and at excessive threat of growing sort 2 diabetes.
Diabetes (Type 1) Exosome RNA |
P241-DB1 |
101Bio |
- |
Ask for price |
Diabetes (Type 2) Exosome RNA |
P241-DB2 |
101Bio |
- |
Ask for price |
Lung Diabetic Disease Lysate |
XBL-10362 |
ProSci |
0.1 mg |
EUR 796.2 |
Description: Human lung tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human lung tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the lung tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The lung tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
Total RNA - Diabetic Disease: Colon |
R1236090Dia-50 |
Biochain |
50 ug |
EUR 421.2 |
Colon Diabetic Disease Lysate |
XBL-10333 |
ProSci |
0.1 mg |
EUR 796.2 |
Description: Human colon tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human colon tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the colon tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The colon tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
Ileum Diabetic Disease Lysate |
XBL-10379 |
ProSci |
0.1 mg |
EUR 796.2 |
Description: Human small intestine: Ileum tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human small intestine: Ileum tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the small intestine: Ileum tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The small intestine: Ileum tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
Total RNA - Diabetic Disease: Stomach |
R1236248Dia-50 |
Biochain |
50 ug |
EUR 421.2 |
Jejunum Diabetic Disease Lysate |
XBL-10381 |
ProSci |
0.1 mg |
EUR 796.2 |
Description: Human small intestine: Jejunum tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human small intestine: Jejunum tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the small intestine: Jejunum tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The small intestine: Jejunum tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
Stomach Diabetic Disease Lysate |
XBL-10387 |
ProSci |
0.1 mg |
EUR 796.2 |
Description: Human stomach tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human stomach tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the stomach tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The stomach tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
Total RNA - Diabetic Disease: Pancreas |
R1236188Dia-50 |
Biochain |
50 ug |
EUR 421.2 |
Duodenum Diabetic Disease Lysate |
XBL-10336 |
ProSci |
0.1 mg |
EUR 796.2 |
Description: Human duodenum tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human duodenum tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the duodenum tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The duodenum tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
Total RNA - Diabetic Disease: Esophagus |
R1236106Dia-50 |
Biochain |
50 ug |
EUR 421.2 |
Esophagus Diabetic Disease Lysate |
XBL-10338 |
ProSci |
0.1 mg |
EUR 796.2 |
Description: Human esophagus tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human esophagus tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the esophagus tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The esophagus tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
Pancrease Diabetic Disease Lysate |
XBL-10371 |
ProSci |
0.1 mg |
EUR 796.2 |
Description: Human pancrease tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human pancrease tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the pancrease tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The pancrease tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
cDNA - Human Diabetic Diseased Tissue: Lung |
C1236152Dia |
Biochain |
40 reactions |
EUR 729 |
cDNA - Human Diabetic Diseased Tissue: Skin |
C1236218Dia |
Biochain |
40 reactions |
EUR 729 |
cDNA - Human Diabetic Diseased Tissue: Brain |
C1236035Dia |
Biochain |
40 reactions |
EUR 729 |
cDNA - Human Diabetic Diseased Tissue: Colon |
C1236090Dia |
Biochain |
40 reactions |
EUR 729 |
cDNA - Human Diabetic Diseased Tissue: Heart |
C1236122Dia |
Biochain |
40 reactions |
EUR 729 |
cDNA - Human Diabetic Diseased Tissue: Liver |
C1236149Dia |
Biochain |
40 reactions |
EUR 729 |
cDNA - Human Diabetic Diseased Tissue: Whole Eye |
C1236108Dia-10 |
Biochain |
10 reactions |
EUR 393 |
cDNA - Human Diabetic Diseased Tissue: Kidney |
C1236142Dia |
Biochain |
40 reactions |
EUR 729 |
cDNA - Human Diabetic Diseased Tissue: Spleen |
C1236246Dia |
Biochain |
40 reactions |
EUR 729 |
Skeletal Muscle Diabetic Disease Lysate |
XBL-10369 |
ProSci |
0.1 mg |
EUR 796.2 |
Description: human skeletal muscle tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human skeletal muscle tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the Skeletal Muscle tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The Skeletal Muscle tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
cDNA - Human Diabetic Diseased Tissue: Lymph Node |
C1236161Dia-10 |
Biochain |
10 reactions |
EUR 393 |
cDNA - Human Diabetic Diseased Tissue: Stomach |
C1236248Dia |
Biochain |
40 reactions |
EUR 729 |
cDNA - Human Diabetic Diseased Tissue: Bone Marrow |
C1236024Dia-10 |
Biochain |
10 reactions |
EUR 420 |
cDNA - Human Diabetic Diseased Tissue: Pancreas |
C1236188Dia |
Biochain |
40 reactions |
EUR 729 |
Pancreas Membrane Diabetic Disease Lysate |
XBL-10785 |
ProSci |
0.1 mg |
EUR 752.1 |
Description: Human pancreas tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human pancreas tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated pancreas tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated pancreas tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
cDNA - Human Diabetic Diseased Tissue: Esophagus |
C1236106Dia |
Biochain |
40 reactions |
EUR 729 |
Membrane Protein - Diabetic Disease: Pancreas |
P3236188Dia |
Biochain |
0.1 mg |
EUR 410 |
Total Protein - Human Diabetic Diseased Tissue: Lung |
P1236152Dia |
Biochain |
1 mg |
EUR 471 |
Total Protein - Human Diabetic Diseased Tissue: Skin |
P1236218Dia |
Biochain |
1 mg |
EUR 471 |
Adipose Subcutaneous Diabetic Disease Lysate |
20-105 |
ProSci |
0.1 mg |
EUR 1508.1 |
Description: Human subcutaneous adipose tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human subcutaneous adipose tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the subcutaneous adipose tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The subcutaneous adipose tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
Total Protein - Human Diabetic Diseased Tissue: Brain |
P1236035Dia |
Biochain |
1 mg |
EUR 471 |
Total Protein - Human Diabetic Diseased Tissue: Colon |
P1236090Dia |
Biochain |
1 mg |
EUR 471 |
Total Protein - Human Diabetic Diseased Tissue: Heart |
P1236122Dia |
Biochain |
1 mg |
EUR 471 |
Total Protein - Human Diabetic Diseased Tissue: Liver |
P1236149Dia |
Biochain |
1 mg |
EUR 471 |
cDNA - Human Diabetic Diseased Tissue: Skeletal Muscle |
C1236171Dia |
Biochain |
40 reactions |
EUR 729 |
Total Protein - Human Diabetic Diseased Tissue: Whole Eye |
P1236108Dia |
Biochain |
1 mg |
EUR 1147 |
Total Protein - Human Diabetic Diseased Tissue: Kidney |
P1236142Dia |
Biochain |
1 mg |
EUR 471 |
Total Protein - Human Diabetic Diseased Tissue: Spleen |
P1236246Dia |
Biochain |
1 mg |
EUR 471 |
Skeletal Muscle Membrane Diabetic Disease Lysate |
XBL-10855 |
ProSci |
0.1 mg |
EUR 752.1 |
Description: human skeletal muscle tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human skeletal muscle tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated Skeletal Muscle tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated Skeletal Muscle tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
cDNA - Human Diabetic Diseased Tissue: Visceral Adipose |
C1236003VisDia-10 |
Biochain |
10 reactions |
EUR 420 |
Membrane Protein - Diabetic Disease: Skeletal Muscle |
P3236171Dia |
Biochain |
0.1 mg |
EUR 410 |
Total Protein - Human Diabetic Diseased Tissue: Adrenal |
P1236004Dia |
Biochain |
1 mg |
EUR 471 |
Total Protein - Human Diabetic Diseased Tissue: Stomach |
P1236248Dia |
Biochain |
1 mg |
EUR 471 |
Total Protein - Human Diabetic Diseased Tissue: Bone Marrow |
P1236024Dia |
Biochain |
1 mg |
EUR 1147 |
Total Protein - Human Diabetic Diseased Tissue: Pancreas |
P1236188Dia |
Biochain |
1 mg |
EUR 471 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Eye |
T1236108Dia |
Biochain |
5 slides |
EUR 662 |
cDNA - Human Diabetic Diseased Tissue: Small Intestine: Ileum |
C1236227Dia |
Biochain |
40 reactions |
EUR 729 |
Total Protein - Human Diabetic Diseased Tissue: Esophagus |
P1236106Dia |
Biochain |
1 mg |
EUR 471 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Lung |
T1236152Dia |
Biochain |
5 slides |
EUR 475 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Skin |
T1236218Dia |
Biochain |
5 slides |
EUR 475 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Brain |
T1236035Dia |
Biochain |
5 slides |
EUR 475 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Colon |
T1236090Dia |
Biochain |
5 slides |
EUR 475 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Heart |
T1236122Dia |
Biochain |
5 slides |
EUR 475 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Liver |
T1236149Dia |
Biochain |
5 slides |
EUR 475 |
cDNA - Human Diabetic Diseased Tissue: Subcutaneous Adipose |
C1236003SubDia-10 |
Biochain |
10 reactions |
EUR 420 |
cDNA - Human Diabetic Diseased Tissue: Small Intestine: Jejunum |
C1236230Dia |
Biochain |
40 reactions |
EUR 729 |
Genomic DNA - Human Diabetic Diseased Tissue: Lung, from a single donor |
D1236152Dia |
Biochain |
50 ug |
EUR 489 |
Genomic DNA - Human Diabetic Diseased Tissue: Skin, from a single donor |
D1236218Dia |
Biochain |
50 ug |
EUR 489 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Kidney |
T1236142Dia |
Biochain |
5 slides |
EUR 475 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Spleen |
T1236246Dia |
Biochain |
5 slides |
EUR 475 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Lung |
T2236152Dia |
Biochain |
5 slides |
EUR 238 |
cDNA - Human Diabetic Diseased Tissue: Small Intestine: Duodenum |
C1236101Dia |
Biochain |
40 reactions |
EUR 729 |
Genomic DNA - Human Diabetic Diseased Tissue: Colon, from a single donor |
D1236090Dia |
Biochain |
50 ug |
EUR 489 |
Genomic DNA - Human Diabetic Diseased Tissue: Heart, from a single donor |
D1236122Dia |
Biochain |
50 ug |
EUR 489 |
Genomic DNA - Human Diabetic Diseased Tissue: Liver, from a single donor |
D1236149Dia |
Biochain |
50 ug |
EUR 489 |
Genomic DNA - Human Diabetic Diseased Tissue: Brain, from a single donor |
D1236035Dia |
Biochain |
50 ug |
EUR 489 |
Total Protein - Human Diabetic Diseased Tissue: Skeletal Muscle |
P1236171Dia |
Biochain |
1 mg |
EUR 471 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Adrenal |
T1236004Dia |
Biochain |
5 slides |
EUR 475 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Stomach |
T1236248Dia |
Biochain |
5 slides |
EUR 475 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Colon |
T2236090Dia |
Biochain |
5 slides |
EUR 238 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Liver |
T2236149Dia |
Biochain |
5 slides |
EUR 238 |
Genomic DNA - Human Diabetic Diseased Tissue: Whole Eye, from a single donor |
D1236108Dia |
Biochain |
50 ug |
EUR 1152 |
Genomic DNA - Human Diabetic Diseased Tissue: Kidney, from a single donor |
D1236142Dia |
Biochain |
50 ug |
EUR 489 |
Genomic DNA - Human Diabetic Diseased Tissue: Spleen, from a single donor |
D1236246Dia |
Biochain |
50 ug |
EUR 489 |
Total Protein - Human Diabetic Diseased Tissue: Visceral Adipose |
P1236003VisDia |
Biochain |
1 mg |
EUR 1147 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Bone Marrow |
T1236024Dia |
Biochain |
5 slides |
EUR 662 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Pancreas |
T1236188Dia |
Biochain |
5 slides |
EUR 475 |
Genomic DNA - Human Diabetic Diseased Tissue: Stomach, from a single donor |
D1236248Dia |
Biochain |
50 ug |
EUR 489 |
Genomic DNA - Human Diabetic Diseased Tissue: Adrenal, from a single donor |
D1236004Dia |
Biochain |
50 ug |
EUR 489 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Esophagus |
T1236106Dia |
Biochain |
5 slides |
EUR 475 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Stomach |
T2236248Dia |
Biochain |
5 slides |
EUR 238 |
Genomic DNA - Human Diabetic Diseased Tissue: Esophagus, from a single donor |
D1236106Dia |
Biochain |
50 ug |
EUR 489 |
Genomic DNA - Human Diabetic Diseased Tissue: Pancreas, from a single donor |
D1236188Dia |
Biochain |
50 ug |
EUR 489 |
Genomic DNA - Human Diabetic Diseased Tissue: Bone Marrow, from a single donor |
D1236024Dia |
Biochain |
50 ug |
EUR 1152 |
Total Protein - Human Diabetic Diseased Tissue: Small Intestine: Ileum |
P1236227Dia |
Biochain |
1 mg |
EUR 471 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Bone Marrow |
T2236024Dia |
Biochain |
5 slides |
EUR 238 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Esophagus |
T2236106Dia |
Biochain |
5 slides |
EUR 238 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Pancreas |
T2236188Dia |
Biochain |
5 slides |
EUR 238 |
Total Protein - Human Diabetic Diseased Tissue: Subcutaneous Adipose |
P1236003SubDia |
Biochain |
1 mg |
EUR 1147 |
Total Protein - Human Diabetic Diseased Tissue: Small Intestine: Duodenum |
P1236101Dia |
Biochain |
1 mg |
EUR 471 |
Total Protein - Human Diabetic Diseased Tissue: Small Intestine: Jejunum |
P1236230Dia |
Biochain |
1 mg |
EUR 471 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Visceral Adipose |
T1236003VisDia |
Biochain |
5 slides |
EUR 662 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Skeletal Muscle |
T1236171Dia |
Biochain |
5 slides |
EUR 475 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Parathyroid |
T2236189Dia |
Biochain |
5 slides |
EUR 629 |
Genomic DNA - Human Diabetic Diseased Tissue: Skeletal Muscle, from a single donor |
D1236171Dia |
Biochain |
50 ug |
EUR 489 |
Genomic DNA - Human Diabetic Diseased Tissue: Visceral Adipose, from a single donor |
D1236003VisDia |
Biochain |
50 ug |
EUR 1152 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Ileum |
T1236227Dia |
Biochain |
5 slides |
EUR 475 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Skeletal Muscle |
T2236171Dia |
Biochain |
5 slides |
EUR 238 |
Genomic DNA - Human Diabetic Diseased Tissue: Small Intestine: Ileum, from a single donor |
D1236227Dia |
Biochain |
50 ug |
EUR 489 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Subcutaneous Adipose |
T1236003SubDia |
Biochain |
5 slides |
EUR 662 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Jejunum |
T1236230Dia |
Biochain |
5 slides |
EUR 475 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Ileum |
T2236227Dia |
Biochain |
5 slides |
EUR 238 |
Genomic DNA - Human Diabetic Diseased Tissue: Small Intestine: Jejunum, from a single donor |
D1236230Dia |
Biochain |
50 ug |
EUR 489 |
Genomic DNA - Human Diabetic Diseased Tissue: Subcutaneous Adipose, from a single donor |
D1236003SubDia |
Biochain |
50 ug |
EUR 1152 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Duodenum |
T1236101Dia |
Biochain |
5 slides |
EUR 475 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Jejunum |
T2236230Dia |
Biochain |
5 slides |
EUR 238 |
Genomic DNA - Human Diabetic Diseased Tissue: Small Intestine: Duodenum, from a single donor |
D1236101Dia |
Biochain |
50 ug |
EUR 489 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Duodenum |
T2236101Dia |
Biochain |
5 slides |
EUR 238 |
Canine C Peptide(C Peptide) ELISA Kit |
ECA0028 |
FN Test |
96T |
EUR 681.12 |
|
Description: Method of detection: Coated with Antigen, Competitive ELISA;Reacts with: Canine;Sensitivity: 0.469 ng/ml |
DIABLO Blocking Peptide |
33R-5520 |
Fitzgerald |
100 ug |
EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of DIABLO antibody, catalog no. 20R-1288 |
DIABLO Blocking Peptide |
DF7017-BP |
Affbiotech |
1mg |
EUR 234 |
Smac/DIABLO Blocking Peptide |
3298BP-50 |
Biovision |
each |
EUR 183.6 |
C Peptide 1 ELISA kit |
55R-IB79101 |
Fitzgerald |
96 wells |
EUR 745.2 |
Description: ELISA kit for the detection of C Peptide 1 in the research laboratory |
Rat C peptide ELISA kit |
E02C0042-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Rat C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat C peptide ELISA kit |
E02C0042-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Rat C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat C peptide ELISA kit |
E02C0042-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Rat C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog C peptide ELISA kit |
E08C0042-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Canine C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog C peptide ELISA kit |
E08C0042-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Canine C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog C peptide ELISA kit |
E08C0042-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Canine C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig C peptide ELISA kit |
E07C0042-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Porcine C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig C peptide ELISA kit |
E07C0042-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Porcine C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig C peptide ELISA kit |
E07C0042-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Porcine C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat C peptide ELISA kit |
E06C0042-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Goat C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat C peptide ELISA kit |
E06C0042-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Goat C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat C peptide ELISA kit |
E06C0042-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Goat C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human C peptide ELISA kit |
E01C0042-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Human C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human C peptide ELISA kit |
E01C0042-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Human C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human C peptide ELISA kit |
E01C0042-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Human C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse C peptide ELISA kit |
E03C0042-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Mouse C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse C peptide ELISA kit |
E03C0042-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Mouse C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse C peptide ELISA kit |
E03C0042-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Mouse C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit C peptide ELISA kit |
E04C0042-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit C peptide ELISA kit |
E04C0042-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit C peptide ELISA kit |
E04C0042-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey C peptide ELISA kit |
E09C0042-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Monkey C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey C peptide ELISA kit |
E09C0042-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Monkey C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey C peptide ELISA kit |
E09C0042-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Monkey C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat C- Peptide, connecting peptide ELISA Kit |
CELI-66099r |
Lifescience Market |
96 Tests |
EUR 1063.2 |
Human C- Peptide, connecting peptide ELISA Kit |
CELI-66099h |
Lifescience Market |
96 Tests |
EUR 988.8 |
Mouse C- Peptide, connecting peptide ELISA Kit |
CELI-66099m |
Lifescience Market |
96 Tests |
EUR 1038 |
Bovine C- Peptide, connecting peptide ELISA Kit |
CELI-66099b |
Lifescience Market |
96 Tests |
EUR 1113.6 |
Canine C- Peptide, connecting peptide ELISA Kit |
CELI-66099d |
Lifescience Market |
96 Tests |
EUR 1113.6 |
Rabbit C- Peptide, connecting peptide ELISA Kit |
CELI-66099Rb |
Lifescience Market |
96 Tests |
EUR 1113.6 |
Chicken C- Peptide, connecting peptide ELISA Kit |
CELI-66099c |
Lifescience Market |
96 Tests |
EUR 1113.6 |
General C- Peptide, connecting peptide ELISA Kit |
CELI-66099Ge |
Lifescience Market |
96 Tests |
EUR 1063.2 |
Porcine C- Peptide, connecting peptide ELISA Kit |
CELI-66099p |
Lifescience Market |
96 Tests |
EUR 1113.6 |
Guinea pig C peptide ELISA kit |
E05C0042-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Guinea pig C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Guinea pig C peptide ELISA kit |
E05C0042-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Guinea pig C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Guinea pig C peptide ELISA kit |
E05C0042-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Guinea pig C peptide in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Procollagen C peptidase ELISA kit |
E02P0624-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Rat Procollagen C peptidase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Procollagen C peptidase ELISA kit |
E02P0624-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Rat Procollagen C peptidase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Procollagen C peptidase ELISA kit |
E02P0624-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Rat Procollagen C peptidase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog Procollagen C peptidase ELISA kit |
E08P0624-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Canine Procollagen C peptidase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog Procollagen C peptidase ELISA kit |
E08P0624-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Canine Procollagen C peptidase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog Procollagen C peptidase ELISA kit |
E08P0624-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Canine Procollagen C peptidase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig Procollagen C peptidase ELISA kit |
E07P0624-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Porcine Procollagen C peptidase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig Procollagen C peptidase ELISA kit |
E07P0624-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Porcine Procollagen C peptidase in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
We searched Medline, Embase, the Cochrane Library, and gray literature sources as much as August 2021 for randomized managed trials (RCTs) that in contrast sotagliflozin with placebo or different antidiabetic brokers in sufferers with sort 2 diabetes. Our main final result was change in HbA1c from baseline.